Series B
Also called Series B funding, Series B financing or a Series B round.
Series B is a startup financing round that usually follows Series A and funds expansion of a business with demonstrated customer demand. In US venture deals, investors typically buy preferred stock with negotiated financial and control rights.
The letter names a funding stage, not a legal test of revenue, profitability or company size. Two companies raising Series B rounds can have very different businesses. A software company might be expanding a sales process; a biotech company might be financing clinical development.
Key takeaways
- Series B investors want evidence that more capital will expand a business that works, rather than just extend the search for one.
- There is no official minimum revenue, round size or valuation for Series B.
- Dilution depends on the valuation, new investment and capitalization terms. A pre-money option-pool increase can dilute founders beyond the headline percentage sold.
- Valuation is only part of the deal. Liquidation preferences, board seats, veto rights and funding conditions affect the founder's eventual outcome.
What Series B money pays for
Series B usually funds expansion: more sales capacity, entry into another market, product development, infrastructure or production capacity. The important question is why those expenses should produce a better business.
For a subscription software company, investors might examine customer retention, sales efficiency, gross margin and whether new salespeople become productive. For a marketplace, they might examine repeat transactions and the economics of entering another city. A hardware company needs evidence about manufacturing costs and delivery reliability.
Growth alone is not enough. Revenue that depends on unusually generous discounts or expensive implementation work might not scale economically.
Build the funding request from the operating plan:
- What milestone should this round finance?
- What will it cost to reach that milestone?
- What cash cushion will remain if progress takes longer?
- What evidence should make the next financing, profitability or another outcome achievable?
If you are still at Series A, these questions help define what that capital needs to prove before the next raise.
How a Series B round works
A US Series B is usually a priced equity financing. The company and investors agree on a valuation and a price per share, then investors purchase newly issued preferred stock.
A lead investor often negotiates the main terms and conducts diligence. Existing investors might participate through contractual pro rata rights or a separately negotiated allocation.
The process moves through:
- Investor discussions and review of the business.
- A term sheet covering price, investment amount and major rights.
- Financial, commercial and legal diligence.
- Definitive agreements, required approvals and closing.
A signed term sheet is not money in the bank. Most commercial terms in a venture term sheet are nonbinding; provisions such as confidentiality or exclusivity can be binding. Funding arrives under the closing terms of the definitive agreements.
Investors will also inspect the cap table. Outstanding SAFEs, convertible notes, warrants and promised equity can change the ownership calculation.
Raising $20 million at an $80 million pre-money valuation
Consider a company with 10 million fully diluted shares before financing. That includes 1 million shares reserved for options. It raises $20 million at an $80 million pre-money valuation.
There are no converting securities, secondary sales or option-pool increases. Existing investors do not buy additional shares.
The arithmetic is:
- Price per share: $80 million ÷ 10 million = $8.
- New shares: $20 million ÷ $8 = 2.5 million.
- Post-money valuation: $80 million + $20 million = $100 million.
- New investor ownership: $20 million ÷ $100 million = 20%.
| Holder | Shares before | Ownership before | Shares after | Ownership after |
|---|---|---|---|---|
| Founders | 5 million | 50% | 5 million | 40% |
| Earlier investors | 4 million | 40% | 4 million | 32% |
| Option pool | 1 million | 10% | 1 million | 8% |
| Series B investor | 0 | 0% | 2.5 million | 20% |
| Total | 10 million | 100% | 12.5 million | 100% |
The founders keep the same number of shares, but their ownership falls from 50% to 40%. That is a 10-percentage-point drop and 20% relative dilution.
The $20 million goes to the company, before transaction costs. It is not a payment to the founders. Founder liquidity would require a separate secondary sale or another arrangement.
Notice the option pool: it falls from 10% to 8%. If the investor requires a larger pool after closing and the increase is included in the pre-money capitalization, existing holders take additional dilution. Ask for a before-and-after cap table, not just a valuation.
Where Series B appears in the documents
The National Venture Capital Association's model documents show how financing terms are divided across agreements. They are templates that counsel adapts to the company and financing, not a guarantee that any particular deal is fair.
Paraphrasing their functions:
| Document | What to examine |
|---|---|
| Term sheet | Proposed valuation, investment amount, capitalization assumptions and major investor rights |
| Stock purchase agreement | Purchase price, closing conditions, company representations and the mechanics of issuing shares |
| Certificate of incorporation | Preferred-stock economics, conversion terms and specified investor approval rights |
| Investors' rights agreement | Information rights, registration rights and participation rights for future offerings |
| Voting agreement | Board-selection arrangements and other voting commitments, including any drag-along provisions |
A high valuation does not cancel unfavorable rights elsewhere.
For example, suppose the Series B investor in the example receives a 1x non-participating liquidation preference. Ignoring other preferences and transaction costs, at a $50 million sale it would choose between its $20 million preference and $10 million from converting into common stock: 20% × $50 million.
It would take $20 million. The founders' headline 40% ownership therefore does not mean they receive 40% of every possible sale price. A full exit model must include the rights of earlier preferred rounds too.
Terms to question before accepting the valuation
There is no universal Series B package. Compare actual proposals using the same capitalization and exit assumptions.
For one published reference, Y Combinator's standard Series A term sheet uses a 1x non-participating liquidation preference. That illustrates a useful negotiating baseline, not a current Series B market benchmark.
Pay particular attention to:
- Option-pool increases. Ask who bears the dilution and whether the pool reflects the actual hiring plan. A pre-money increase is not economically neutral to existing holders.
- Preference multiples and participation. A participating investor can receive its preference and then share in the remaining proceeds, subject to the agreed terms. Model the payout rather than judging the headline valuation alone.
- Seniority. Determine whether Series B gets paid before earlier preferred investors or alongside them. Stacked preferences can materially reduce what common shareholders receive.
- Board and veto rights. A board seat and a right to block specified company actions are different powers. Review both.
- Conditional funding. Distinguish cash available at closing from later installments tied to milestones or other conditions. A large announced commitment is not necessarily cash the company can immediately spend.
Series A vs. Series B
The difference is primarily the evidence expected, not a formal boundary.
| Question | Series A | Series B |
|---|---|---|
| What is the investment thesis? | The company has a promising business and a credible growth plan | The company has evidence that the business can expand |
| What does the capital often fund? | Product development and establishing repeatable growth | Expanding proven channels, capacity or markets |
| What gets tested? | Product-market fit and the route to a durable business | Repeatability, growth economics and execution at greater scale |
| What security is used? | Usually preferred stock in a priced round | Usually another series of preferred stock |
| Is there a universal revenue threshold? | No | No |
These are expectations, not certification standards. A company does not become Series B-ready simply because it has already raised Series A.
Choosing investors for a Series B process
Look for investors whose current strategy fits the stage, sector and investment size you need. A firm that made a small seed investment in a famous company is not necessarily a suitable Series B lead.
Before prioritizing a firm, establish whether it leads rounds, what ownership it seeks, who can sponsor the investment internally and whether it has competing portfolio interests.
Then match the financing story to the operating evidence. If the claim is that another sales team will produce profitable growth, show how existing teams perform. If expansion depends on a regulatory or manufacturing milestone, explain the cost and risk directly.
Questions founders ask
What's the difference between Series A and B funding?
Series A often finances the work needed to establish repeatable growth. Series B usually finances expansion after more of that evidence exists. Both can use preferred stock with similar contractual machinery. The letter alone does not tell you how mature the company is or whether its terms are founder-friendly.
How long does it take from Series A to Series B?
There is no required interval. The right timing depends on the milestones funded by Series A, spending and the evidence available for the next raise. Work backward from the cash forecast and allow room for diligence and negotiation. Waiting until cash is nearly exhausted weakens your alternatives.
How hard is it to get Series B funding?
The difficult part is proving that more money will produce a stronger business. Growing revenue with weak retention, worsening acquisition costs or a narrow customer base can make that case difficult. Prepare evidence at the customer-cohort, product or sales-channel level rather than relying only on a company-wide growth chart.
Does a company need to be profitable to raise Series B?
No. Investors can fund a loss-making company if they believe the spending creates a valuable business. But distinguish investment in expansion from losses embedded in each customer relationship or transaction. A credible plan explains what improves with scale, what will not and how much capital the business still needs.
